Moody’s affirms Palmetto Health’s ‘Baa1’ rating

Moody’s Investors Service has affirmed Columbia, S.C.-based Palmetto Health’s “Baa1” rating, affecting $484 million of debt.

Advertisement

The rating affirmation reflects a number of factors, including Palmetto’s large size and important role in its market as an academic medical center and teaching hospital for Columbia-based University of South Carolina School of Medicine.

Palmetto Health also faces several challenges, including integration risks with a recently acquired hospital.

The outlook is stable, reflecting Moody’s Investors Service’s view that Palmetto will maintain operating performance at its current levels.

More articles on healthcare finance:
Coding error points to administrative glitch at St. Mark’s Hospital
As hospitals increasingly hire oncologists, chemo costs rise
US annual spending on prescription drugs to reach $400 billion by 2020

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Financial Management

  • Baylor College of Medicine and Texas Children’s Hospital established an affiliation more than 70 years ago in the Texas Medical…

  • Fitch revised Ontario, Calif.-based Prime Healthcare Services’ outlook to positive and affirms its “B” rating.  The revised outlook reflects Fitch’s…

  • Brentwood, Tenn.-based Lifepoint Health, a health system owned by private equity firm Apollo Global Management, has largely grown over the…

Advertisement

Comments are closed.